Search Within

Kamal Nand Menghrajani

Formats
  1. Meeting Abstract (24)
  2. Journal Article (17)
  3. Research Letter (2)
Groups
  1. Department of Medicine (43)
  2. Hematologic Malignancies, Division of (43)
  3. Weinberg Fellows (43)
  4. Center for Hematologic Malignancies (42)
  5. Adult Leukemia (41)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (30)

More Groups

People
  1. Ross Levine (27)
  2. Martin Tallman (23)
  3. Christopher Famulare (21)
  4. Jacob Glass (18)
  5. Sean Devlin (17)
  6. Mikhail Roshal (14)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (5)
  6. 2020 (11)

More Years

Publications
  1. Blood (21)
  2. Blood Advances (5)
  3. American Journal of Hematology (2)
  4. Haematologica (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Cell Stem Cell (1)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Nature Publishing Group (4)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Immunophenotypic lineage assessment by multiparameter flow cytometry provides more precise MDS prognosis
    Meeting Abstract

    Onyekwere, I.; Garcia, J. P.; Menghrajani, K.; Chan, A.; Famulare, C.; Patel, M. A.; Philip, J.; Tallman, M. S.; Klimek, V. M.; Levine, R. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Germline contributions to clonal hematopoiesis in solid cancer patients
    Meeting Abstract

    Franch-Expósito, S.; Srinivasan, P.; Ptashkin, R.; Bandlamudi, C.; Bolton, K. L.; Gedvilaite, E.; Menghrajani, K.; Mandelker, D.; Comen, E.; Norton, L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Research Letter

    Bernard, E.; Nannya, Y.; Hasserjian, R. P.; Devlin, S. M.; Tuechler, H.; Medina-Martinez, J. S.; Yoshizato, T.; Shiozawa, Y.; Saiki, R.; Malcovati, L.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes
    Journal Article

    Menghrajani, K.; Zhang, Y.; Famulare, C.; Devlin, S. M.; Tallman, M. S.
    Leukemia Research (2020)

    Fulltext@MSK | Save
  • Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases
    Meeting Abstract

    Liu, Y.; Mata, D.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M.; Zhang, Y.; Dogan, A.; Tallman, M.; Levine, R.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients
    Meeting Abstract

    Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: Results from an international collaborative study
    Journal Article

    Kayser, S.; Hills, R. K.; Luskin, M. R.; Brunner, A. M.; Terré, C.; Westermann, J.; Menghrajani, K.; Shaw, C.; Baer, M. R.; Elliott, M. A.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • A phase Ib/II study of the histone methyltransferase inhibitor pinometostat in combination with azacitidine in patients with 11q23-rearranged acute myeloid leukemia
    Meeting Abstract

    Menghrajani, K.; Cai, S. F.; Devlin, S. M.; Armstrong, S. A.; Piekarz, R.; Rudek, M.; Tallman, M. S.; Stein, E. M.
    Blood (2019)

    Fulltext@MSK | Save